Academy of Athens Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02281305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Biomedical Research Foundation, Academy of Athens | Biomedical Research Foundation of Academy of Athens | Biomedical Research Foundation of the Academy of Athens

Active Ingredients

Drugs in Phase 4 Trials (2)

colchicine (colbenemid) (1 trial)

umbilical cord blood platelet lysate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 4)

Inflammation (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2